spot_img
Saturday, August 13, 2022
More
    HomeHealthHere's why I think the FDA will approve Amylyx's ALS drug

    Here’s why I think the FDA will approve Amylyx’s ALS drug

    -



    The odds that Amylyx Prescribed drugs wins approval from the Meals and Drug Administration for Albrioza, its remedy for ALS, have elevated considerably over the previous two weeks. My prediction: The FDA grants accelerated approval to Albrioza, with the requirement that Amylyx affirm the drug’s profit for sufferers with outcomes from the continued Section 3 research — knowledge anticipated in 2024.

    I’m able to making a constructive prediction sometimes. I’m not all doom and gloom. This one feels proper, with echoes of how the FDA acted on eteplirsen, the Duchenne muscular dystrophy drug, in 2016, and extra not too long ago, Biogen’s Alzheimer’s remedy Aduhelm, in 2021.

    Unlock this text by subscribing to STAT+ and revel in your first 30 days free!

    GET STARTED





    Source link

    Related articles

    Stay Connected

    0FansLike
    0FollowersFollow
    3,434FollowersFollow
    0SubscribersSubscribe
    spot_img

    Latest posts